Marshall Wace North America’s Prestige Consumer Healthcare PBH Stock Holding History

Marshall Wace North America’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-34,972	Closed	-$1.28M	–	1389
2020 Q1	$1.28M	Buy	+34,972	New	+$1.36M	0.01%	568
2019 Q4	–	Sell	-1,992	Closed	-$69K	–	1522
2019 Q3	$69K	Buy	+1,992	New	+$65.6K	﹤0.01%	1115
2019 Q1	–	Sell	-38,027	Closed	-$1.17M	–	1818
2018 Q4	$1.17M	Buy	+38,027	New	+$1.39M	0.01%	574
2018 Q3	–	Sell	-8,535	Closed	-$327K	–	1255
2018 Q2	$327K	Buy	+8,535	New	+$288K	﹤0.01%	1166
2018 Q1	–	Sell	-141,339	Closed	-$6.28M	–	1630
2017 Q4	$6.28M	Buy	+141,339	New	+$6.44M	0.03%	513
2017 Q3	–	Sell	-4,839	Closed	-$257K	–	1445
2017 Q2	$257K	Buy	+4,839	New	+$259K	﹤0.01%	1183

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Marshall Wace North America's PBH Position: Q2 2020 in Review

Marshall Wace North America sold out of Prestige Consumer Healthcare (PBH) in Q2 2020, closing a stake of 34,972 shares — an estimated $1.28M sold.

Marshall Wace North America first reported a position in PBH in Q2 2017 and held it in 6 quarters. The position peaked at $6.28M in Q4 2017. 253 funds tracked by Wall St. Rank hold PBH as of Q2 2020.

Marshall Wace North America reported no remaining Prestige Consumer Healthcare position as of Q2 2020 after selling out during the quarter.
Marshall Wace North America sold 34,972 Prestige Consumer Healthcare shares in Q2 2020, an estimated $1.28M.
Marshall Wace North America first reported a position in Prestige Consumer Healthcare in Q2 2017 and held it in 6 quarters.
Marshall Wace North America's Prestige Consumer Healthcare position peaked at $6.28M in Q4 2017.
253 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2020.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.